Overview

Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and efficacy of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) in patients with glaucoma or ocular hypertension who have elevated intraocular pressure (IOP) on brimonidine/timolol ophthalmic solution.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol